Home » Stocks » ADTX

Aditx Therapeutics, Inc. (ADTX)

Stock Price: $2.37 USD 0.00 (0.00%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $2.35 -0.02 (-0.84%) Jan 15, 7:45 PM
Market Cap 28.98M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 7.44M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $2.37
Previous Close $2.37
Change ($) 0.00
Change (%) 0.00%
Day's Open 2.46
Day's Range 2.31 - 2.47
Day's Volume 772,204
52-Week Range 1.70 - 7.60

News

There are no news available yet.

About ADTX

ADiTx Therapeutics, a life sciences company, focuses on developing nucleic acid-based technologies for addressing the rejection of transplanted organs, autoimmune diseases, and allergies. The company is developing Apoptotic DNA Immunotherapy (ADi), a nucleic acid-based technology that utilizes an approach, which mimics the way the body naturally induces tolerance to its own tissues. It also develops ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. The company has a license agreement with Loma ... [Read more...]

Industry
Biotechnology
IPO Date
Jun 30, 2020
CEO
Amro A. Albanna
Employees
2
Stock Exchange
NASDAQ
Ticker Symbol
ADTX
Full Company Profile

Financial Performance

Financial Statements